A nine-month clinical trial of postmenopausal women with confirmed vitamin D deficiency found that daily supplementation with 1,000 international units of vitamin D3 produced measurable improvements in two hormones tied to insulin sensitivity and inflammation. Participants who took the supplement saw adiponectin rise 18.6% and resistin fall 32.4%, while blood levels of 25-hydroxyvitamin D climbed 45.4%. For women in their fifties and sixties, these changes point to a practical, low-cost lever for protecting metabolic health during and after the menopause transition.
What the trial measured and who took part
The research was a controlled study published in the journal Menopause. It enrolled 160 postmenopausal women between 50 and 65 years old whose blood tests confirmed vitamin D deficiency. Participants were randomly assigned to two groups: one received 1,000 IU of vitamin D3 each day, the other received a placebo. The trial ran for nine months.
The investigators focused on two adipokine hormones, signaling proteins released by fat tissue that influence how the body handles sugar and inflammation:
- Adiponectin, which supports insulin sensitivity and is generally found at lower levels in people with obesity and metabolic dysfunction.
- Resistin, which is linked to insulin resistance and higher inflammation.
Higher adiponectin combined with lower resistin is the pattern associated with healthier metabolism, and that is the pattern the supplement group moved toward.
The headline numbers from the study
After nine months at 1,000 IU per day, women in the vitamin D3 group showed:
- An 18.6% increase in adiponectin compared with placebo.
- A 32.4% decrease in resistin compared with placebo.
- A 45.4% rise in blood 25-hydroxyvitamin D, the standard marker clinicians use to gauge vitamin D status.
The placebo group moved the other way on the vitamin marker, dropping 18.5% over the same nine months, which suggests seasonal or behavioral factors can pull levels down even without supplementation.
Why metabolic health gets harder after menopause
Estrogen plays a broad role in how the body stores fat, handles glucose and protects blood vessels. As estrogen falls during the menopause transition, many women see shifts in body composition, blood sugar regulation and cardiovascular risk. The two hormones in this trial sit directly on those pathways. Adiponectin helps tissues respond to insulin more effectively; resistin pushes in the opposite direction and adds to inflammatory load. Moving both in a favorable direction is the kind of change that can show up in daily energy, weight management and long-term diabetes risk.
How vitamin D fits into the broader diabetes picture
The findings align with a wider body of work connecting vitamin D status to glucose control. A 2025 review in Recent Progress in Nutrition laid out several mechanisms. Vitamin D receptors sit on pancreatic beta cells, the insulin-producing cells, and the vitamin also helps regulate genes involved in glucose uptake and lipid metabolism in muscle and fat tissue.
Earlier research adds context on scale:
- One prior study reported vitamin D deficiency in 70% of patients with Type 2 diabetes, and severely deficient individuals were 39 times more likely to carry that diagnosis.
- Two 2018 meta-analyses covering 28 controlled trials and nearly 4,000 adults who were prediabetic, overweight or obese found that vitamin D supplementation significantly improved glucose measurements and insulin sensitivity.
About 29% of U.S. adults are estimated to be deficient in vitamin D, so the population that could benefit is large.
What supports vitamin D’s work in the body
Several nutrients work alongside vitamin D in shared metabolic pathways:
- Magnesium is required by more than 300 enzyme reactions, including several involved in carbohydrate and fat metabolism.
- B vitamins, particularly B6 and B12, help regulate estrogen levels and support adrenal hormone production.
- Zinc supports insulin function and has been shown to improve insulin resistance in women with polycystic ovary syndrome.
- Probiotics help maintain a balanced gut microbiome, which can influence hormone balance and inflammation.
None of these replace the basics. Regular exercise, adequate sleep, stress management and a diet built around whole foods remain the foundation of metabolic health, with supplementation layered on top when blood work shows a gap.
Practical takeaways for women in their fifties and beyond
For postmenopausal women with confirmed vitamin D deficiency, the trial supports a clear course of action: 1,000 IU of vitamin D3 daily for at least nine months produced statistically meaningful changes in adiponectin and resistin. Given how common deficiency is, a blood test to check 25-hydroxyvitamin D is a reasonable step for women approaching or in the early years of menopause.
Food sources add to what a supplement provides. Egg yolks, oily fish such as salmon and sardines, and fortified dairy products all contribute dietary vitamin D, though it is difficult to reach optimal levels from food alone. Sunlight is another natural source, with synthesis affected by latitude, season and sunscreen use, so it is not a reliable year-round strategy in many regions.
Dietary supplements in the United States are not reviewed by the FDA for safety and effectiveness before they reach store shelves, so reading labels, choosing products tested by independent labs and discussing any new regimen with a physician, especially for those on medication or managing chronic conditions, is the safer path.
FAQ
How much vitamin D3 did the trial use, and for how long?
Participants took 1,000 international units of vitamin D3 every day for nine months.
Which hormones changed and by how much?
Adiponectin rose 18.6% and resistin fell 32.4% in the supplement group compared with placebo. Blood 25-hydroxyvitamin D rose 45.4% in the supplement group and fell 18.5% in the placebo group.
Who was in the study?
The trial enrolled 160 postmenopausal women aged 50 to 65 with confirmed vitamin D deficiency. The findings were reported in Menopause.
